Next Article in Journal
Development of Proteomics-Based Fungicides: New Strategies for Environmentally Friendly Control of Fungal Plant Diseases
Next Article in Special Issue
Identification of Receptor Tyrosine Kinase, Discoidin Domain Receptor 1 (DDR1), as a Potential Biomarker for Serous Ovarian Cancer
Previous Article in Journal
Isolation and Characterization of Microsatellite Loci in the Asian Rice Gall Midge (Orseolia oryzae) (Diptera: Cecidomyiidae)
Previous Article in Special Issue
Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
Open AccessReview

MALDI Imaging Mass Spectrometry (MALDI-IMS)―Application of Spatial Proteomics for Ovarian Cancer Classification and Diagnosis

1
Adelaide Proteomics Centre, School of Molecular and Biomedical Science, The University of Adelaide, SA 5005, Adelaide, Australia
2
Robinson Institute, Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, The University of Adelaide, SA 5005, Adelaide, Australia
3
Surgical Pathology, SA Pathology, SA 5000, Adelaide, Australia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2011, 12(1), 773-794; https://doi.org/10.3390/ijms12010773
Received: 1 December 2010 / Revised: 10 January 2011 / Accepted: 17 January 2011 / Published: 21 January 2011
(This article belongs to the Special Issue Cancer Molecules in Ovarian Cancer)
MALDI imaging mass spectrometry (MALDI-IMS) allows acquisition of mass data for metabolites, lipids, peptides and proteins directly from tissue sections. IMS is typically performed either as a multiple spot profiling experiment to generate tissue specific mass profiles, or a high resolution imaging experiment where relative spatial abundance for potentially hundreds of analytes across virtually any tissue section can be measured. Crucially, imaging can be achieved without prior knowledge of tissue composition and without the use of antibodies. In effect MALDI-IMS allows generation of molecular data which complement and expand upon the information provided by histology including immuno-histochemistry, making its application valuable to both cancer biomarker research and diagnostics. The current state of MALDI-IMS, key biological applications to ovarian cancer research and practical considerations for analysis of peptides and proteins on ovarian tissue are presented in this review. View Full-Text
Keywords: MALDI; imaging; mass spectrometry; ovarian cancer; grading; biomarker MALDI; imaging; mass spectrometry; ovarian cancer; grading; biomarker
Show Figures

Graphical abstract

MDPI and ACS Style

Gustafsson, J.O.R.; Oehler, M.K.; Ruszkiewicz, A.; McColl, S.R.; Hoffmann, P. MALDI Imaging Mass Spectrometry (MALDI-IMS)―Application of Spatial Proteomics for Ovarian Cancer Classification and Diagnosis. Int. J. Mol. Sci. 2011, 12, 773-794.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop